Discover

ANTX
AN2 Therapeutics, Inc.
4.70
2 x 3.58
2 x 5.90
bid
ask
-
0.14
2.89%
2 @ 04:00 PM
4.70 +0.00 (0.00%)
Ytd312.28%
1y347.62%
4.59
day range
5.01
1.00
52 week range
6.91
Open4.82Prev Close4.84Low4.59High5.01Mkt Cap169.28M
Vol112.72KAvg Vol332.36KEPS-1.10P/EN/AForward P/E-1.17
Beta-0.22Short Ratio0.82Inst. Own52.31%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1450-d Avg4.58200-d Avg2.441yr Est2.67

ANTX News

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Gainers Pulsenmore (NASDAQ:PLSM) stock increased by 152.0% to $8.59 during Wednesday's pre-mark

benzinga.com
AN2 Therapeutics Announces Results From Two Studies Evaluating Its Oral CPSF3 Inhibitor, AN2-502998,

AN2 Therapeutics, Inc. (NASDAQ:ANTX) a clinical-stage biopharmaceutical company developing novel sma

benzinga.com
AN2 Therapeutics Announces Results From Two Studies Evaluating Oral CPSF3 Inhibitor, AN2-502998, For

Parasite elimination achieved with 28-day treatment in 100% of nonhuman primates (NHPs) naturally in

benzinga.com
Leerink Partners Upgrades AN2 Therapeutics to Outperform, Announces $9 Price Target

Leerink Partners analyst Joseph Schwartz upgrades AN2 Therapeutics (NASDAQ:ANTX) from Market Perf

12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

benzinga.com
AN2 Therapeutics Initiates Phase 2 Trial Of leucyl-tRNA Synthetase (LeuRS) Mycobacterium Abscessus,

AN2 Therapeutics, Inc. (NASDAQ:ANTX), a clinical-stage biopharmaceutical company developing novel sm

benzinga.com
AN2 Therapeutics Q4 EPS $(0.29) Misses $(0.24) Estimate

AN2 Therapeutics (NASDAQ:ANTX) reported quarterly losses of $(0.29) per share which missed the analy

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

AN2 Therapeutics Stock Cools Off After 90% Rally
benzinga.com
AN2 Therapeutics Stock Cools Off After 90% Rally

AN2 Therapeutics stock dips in premarket after a 90% surge tied to a $40 million equity raise.

AN2 Therapeutics Stock Jumps 90% Monday: What's Driving The Action?
benzinga.com
AN2 Therapeutics Stock Jumps 90% Monday: What's Driving The Action?

AN2 Therapeutics Inc (NASDAQ: ANTX) shares are surging Monday afternoon after the company announced

12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

benzinga.com
AN2 Therapeutics Plans Phase 2 Trial Of Oral Epetraborole In Polycythemia Vera; Study To Begin Q3 20

Substantial clinical evidence provides rationale to initiate Phase 2 study in PVPhase 2 study expect

benzinga.com
The FDA Clears Oregon Health & Science University's Investigational New Drug Application To Proceed

AN2 aims to advance oral treatment option for patients currently reliant on complex, off-label IV th

benzinga.com
AN2 Therapeutics Q3 EPS $(0.31) Misses $(0.30) Estimate

AN2 Therapeutics (NASDAQ:ANTX) reported quarterly losses of $(0.31) per share which missed the analy

benzinga.com
AN2 Therapeutics Announces Collaboration Agreement With GSK To Develop New Therapies For TB

AN2 awarded third year of funding from Gates FoundationAN2 Therapeutics, Inc. (NASDAQ:ANTX), a bioph

benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

benzinga.com
AN2 Therapeutics Q2 EPS $(0.21) Beats $(0.30) Estimate

AN2 Therapeutics (NASDAQ:ANTX) reported quarterly losses of $(0.21) per share which beat the analyst

benzinga.com
AN2 Therapeutics Completed Its 200-patient Observational Study In Acute Melioidosis. The Study Evalu

Study highlights high mortality despite standard of care and provides critical data to optimize desi

benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session

benzinga.com
Nasdaq Edges Lower; ContextLogic Shares Surge

U.S. stocks traded mostly higher toward the end of trading, while the Nasdaq Composite moved slightl

benzinga.com
Why Big Lots Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Da

Shares of Big Lots, Inc. (NYSE: BIG) fell sharply during Monday’s session after the company reporte

benzinga.com
Dow Surges Over 150 Points; Gilead Sciences To Acquire CymaBay Therapeutics For $4.3B

U.S. stocks traded higher midway through trading, with the Dow Jones index jumping over 150 points o

benzinga.com
US Stocks Mixed; Trimble Issues Weak Outlook

U.S. stocks traded mixed this morning, with the Dow Jones index falling around 20 points on Monday.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  Friday's session saw 100 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  On Thursday, 498 companies reached new 52-week lows.

benzinga.com
Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday

Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesda

benzinga.com
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday

Gainers

benzinga.com
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday

Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28

benzinga.com
Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday

Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the

benzinga.com
Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Da

Gainers Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  On Thursday, 588 stocks hit new 52-week lows.

benzinga.com
89 Biggest Movers From Friday

Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 951 companies hit new 52-week lows.

benzinga.com
79 Biggest Movers From Yesterday

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 154.7% to settle at $12.10 on Tuesday

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  On Wednesday, 216 stocks hit new 52-week lows.